July 20 (Reuters) - Australian Competition and Consumer Commission (ACCC):
- ACL'S PROPOSED ACQUISITION OF HEALIUS RAISES CONCERNS
- HAS OUTLINED SIGNIFICANT PRELIMINARY COMPETITION CONCERNS WITH AUSTRALIAN CLINICAL LABS LIMITED’S PROPOSED ACQUISITION OF HEALIUS
- CONCERNED THAT PROPOSED ACQUISITION WOULD BE LIKELY TO SUBSTANTIALLY LESSEN COMPETITION IN AUSTRALIAN PATHOLOGY SERVICES MARKETS
- PROPOSED ACQUISITION WOULD COMBINE TWO OF TOP THREE PROVIDERS OF PATHOLOGY SERVICES, INCREASING CONCENTRATION IN ALREADY CONCENTRATED MARKETS
- ACCC INVITES SUBMISSIONS IN RESPONSE TO THE STATEMENT OF ISSUES BY 10 AUGUST 2023
- PRELIMINARY VIEW IS COMBINED ACL AND HEALIUS MAY BE ABLE TO INCREASE PRICES OR REDUCE SERVICE QUALITY IN BIDS FOR PUBLIC HOSPITAL TENDERS
(([email protected];))
News: ACL Australia's ACCC Says ACL'S Proposed Acquisition Of Healius Raises Concerns
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.60 |
Change
-0.030(1.14%) |
Mkt cap ! $510.6M | |||
| Open | High | Low | Value | Volume |
| $2.64 | $2.65 | $2.59 | $901.1K | 345.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18300 | $2.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.62 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
| ACL (ASX) Chart |